Prévisions du marché du traitement de la sarcopénie en Asie-Pacifique jusqu’en 2030 – Analyse régionale – par type de traitement (supplément de vitamine D et de calcium, supplément de protéines, supplément de vitamine B12 et autres) et canal de distribution (pharmacies, canaux de vente au détail, canaux en ligne et autres)

BMIRE00030384 | Pages: 78 | Pharmaceuticals | Jul 2024 | Type: Regional | Status: Published
Le marché du traitement de la sarcopénie en Asie-Pacifique était évalué à 696,85 millions de dollars américains en 2022 et devrait atteindre 1 164,04 millions de dollars américains d’ici 2030 ; on estime qu\'il enregistrera un TCAC de 6,6 % de 2022 à 2030.

Les produits en phase d\'essai clinique stimulent le marché du traitement de la sarcopénie en Asie-Pacifique

Quelques acteurs majeurs opérant sur le marché du traitement de la sarcopénie sont de plus en plus nombreux. se concentrer sur le développement de médicaments pour traiter la sarcopénie. De nouveaux traitements contre la sarcopénie sont actuellement développés et testés dans le cadre d\'essais cliniques. Quelques-uns de ces produits sont mentionnés ci-dessous :

Tableau 1. Médicament contre la sarcopénie en cours de développement clinique

Nom de la société Interventions Conditions Stade de l\'essai clinique

Abbott Nutrition Medical Food avec AN777

Formule nutritionnelle orale Malnutrition

Sarcopénie PHASE3

Nutricia Research Complément alimentaire : Bolus ONS A

Complément alimentaire : Bolus ONS B

Complément alimentaire : Bolus ONS C

Complément alimentaire : Bolus ONS D Sarcopénie PHASE1

Novartis Pharmaceuticals Médicament : Bimagrumab Sarcopénie PHASE2

McMaster University Comportemental : Réduction progressive de la sarcopénie PHASE1

Metabolic Technologies Inc. Complément alimentaire : Placebo et Médicament : HMB Plus Vitamine D

Comportemental : Sans exercice

Comportemental : Sarcopénie à l\'exercice PHASE1

Merck Sharp & Dohme LLC Médicament : Comparateur MK-077 et Médicament : Comparateur Placebo Sarcopénie PHASE2

Immunotec Inc. Complément alimentaire : Immunocal

Complément alimentaire : Caséine vieillissement et sarcopénie PHASE2 < br>
Produit combiné Lijun Yang : Intervention intensive de 3 mois pour la sarcopénie PHASE4

Regeneron Pharmaceuticals Médicament : REGN1033 (SAR391786)

Médicament : Placebo Sarcopénie PHASE2

Source : Sites Web des entreprises et analyse Insight Partners. Par conséquent, le pipeline croissant de médicaments qui se trouvent à différents stades de développement clinique présente des opportunités significatives pour la croissance du marché du traitement de la sarcopénie.

Aperçu du marché du traitement de la sarcopénie en Asie-Pacifique

Le marché du traitement de la sarcopénie en Asie-Pacifique est segmenté en Chine, en Inde, au Japon, en Corée du Sud, en Australie et dans le reste de l\'Asie-Pacifique. L’Asie-Pacifique devrait enregistrer le TCAC le plus rapide du marché mondial au cours de la période de prévision. L\'Asie est le continent le plus peuplé du monde, avec une population vieillissant rapidement, et les problèmes liés à la sarcopénie deviennent de plus en plus répandus dans plusieurs pays asiatiques. Les Asiatiques menaient des modes de vie et des habitudes alimentaires extrêmement différents de ceux des habitants du monde occidental. En Asie, la sarcopénie chez les personnes âgées est plus fréquente chez les hommes (prévalence 9,6-22,1 %) que chez les femmes (prévalence 7,7-21,8 %). Le Groupe de travail asiatique sur la sarcopénie (AWGS) vise à promouvoir la recherche sur la sarcopénie en Asie.

Revenus et prévisions du marché du traitement de la sarcopénie en Asie-Pacifique jusqu\'en 2030 (millions de dollars américains)

Segmentation du marché du traitement de la sarcopénie en Asie-Pacifique

Le marché du traitement de la sarcopénie en Asie-Pacifique est classé par type de traitement. , le canal de distribution et le pays.

En fonction du type de traitement, le marché du traitement de la sarcopénie en Asie-Pacifique est segmenté en supplément de vitamine D et de calcium, supplément de protéines, supplément de vitamine B12 et autres. Le segment des suppléments de vitamine D et de calcium détenait la plus grande part de marché du traitement de la sarcopénie en Asie-Pacifique en 2022.

En termes de canal de distribution, le marché du traitement de la sarcopénie en Asie-Pacifique est segmenté en pharmacies, canaux de vente au détail, canaux en ligne et autres. . Le segment des pharmacies détenait la plus grande part de marché du traitement de la sarcopénie en Asie-Pacifique en 2022.

Par pays, le marché du traitement de la sarcopénie en Asie-Pacifique est segmenté en Chine, Inde, Japon, Australie, Corée du Sud et reste de l\'Asie-Pacifique. . La Chine a dominé la part de marché du traitement de la sarcopénie en Asie-Pacifique en 2022.

Abbott Laboratories, Bayer AG, Metagenics LLC, Nestle Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp et GSK Plc sont quelques-uns des les principales entreprises opérant sur le marché du traitement de la sarcopénie en Asie-Pacifique.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Sarcopenia Treatment Market - Key Industry Dynamics

4.1 Asia Pacific Sarcopenia Treatment Market - Key Industry Dynamics

4.2 Market Drivers

4.2.1 Upsurge in Geriatric Population

4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults

4.3 Key Market Restraints:

4.3.1 Unavailability of Direct Interventions

4.4 Key Market Opportunities:

4.4.1 Products in Clinical Trial Phases

4.5 Future Trends:

4.5.1 Rising Awareness About Sarcopenia

4.6 Impact of Drivers and Restraints:

5. Sarcopenia Treatment Market - Asia Pacific Market Analysis

5.1 Asia Pacific Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030

5.2 Asia Pacific Sarcopenia Treatment Market Forecast and Analysis

6. Asia Pacific Sarcopenia Treatment Market Analysis - By Treatment Type

6.1 Vitamin D and Calcium Supplement

6.1.1 Overview

6.1.2 Vitamin D and Calcium Supplement: Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

6.2 Protein Supplement

6.2.1 Overview

6.2.2 Protein Supplement : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

6.3 Vitamin B12 Supplement

6.3.1 Overview

6.3.2 Vitamin B12 Supplement: Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

6.4 Others

6.4.1 Overview

6.4.2 Others : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Sarcopenia Treatment Market Analysis - By Distribution Channel

7.1 Pharmacies

7.1.1 Overview

7.1.2 Pharmacies : Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

7.2 Retail Channels

7.2.1 Overview

7.2.2 Retail Channels : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7.3 Online Channels

7.3.1 Overview

7.3.2 Online Channels : Asia Pacific Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7.4 Others

7.4.1 Overview

7.4.2 Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Sarcopenia Treatment Market - Country Analysis

8.1 Asia Pacific

8.1.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country

8.1.1.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country

8.1.1.2 China Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.2.1 China Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.2.2 China Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.3 India Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.3.1 India Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.3.2 India Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.4 Japan Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.4.1 Japan Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.4.2 Japan Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.5 South Korea Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.5.1 South Korea Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.5.2 South Korea Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.6 Australia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.6.1 Australia Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.6.2 Australia Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.7 Rest of Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.7.1 Rest of Asia Pacific Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.7.2 Rest of Asia Pacific Sarcopenia Treatment Market Breakdown by Distribution Channel

9. Sarcopenia Treatment Market-Industry Landscape

9.1 Overview

9.2 Growth Strategies in the Sarcopenia Treatment Market

9.3 Inorganic Growth Strategies

9.3.1 Overview

9.4 Organic Growth Strategies

9.4.1 Overview

10. Company Profiles

10.1 Abbott Laboratories

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Products and Services

10.1.4 Financial Overview

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 Bayer AG

10.2.1 Key Facts

10.2.2 Business Description

10.2.3 Products and Services

10.2.4 Financial Overview

10.2.5 SWOT Analysis

10.2.6 Key Developments

10.3 Metagenics LLC

10.3.1 Key Facts

10.3.2 Business Description

10.3.3 Products and Services

10.3.4 Financial Overview

10.3.5 SWOT Analysis

10.3.6 Key Developments

10.4 Nestle Health Science SA

10.4.1 Key Facts

10.4.2 Business Description

10.4.3 Products and Services

10.4.4 Financial Overview

10.4.5 SWOT Analysis

10.4.6 Key Developments

10.5 Novartis AG

10.5.1 Key Facts

10.5.2 Business Description

10.5.3 Products and Services

10.5.4 Financial Overview

10.5.5 SWOT Analysis

10.5.6 Key Developments

10.6 Pfizer Inc

10.6.1 Key Facts

10.6.2 Business Description

10.6.3 Products and Services

10.6.4 Financial Overview

10.6.5 SWOT Analysis

10.6.6 Key Developments

10.7 Sanofi SA

10.7.1 Key Facts

10.7.2 Business Description

10.7.3 Products and Services

10.7.4 Financial Overview

10.7.5 SWOT Analysis

10.7.6 Key Developments

10.8 Amway Corp

10.8.1 Key Facts

10.8.2 Business Description

10.8.3 Products and Services

10.8.4 Financial Overview

10.8.5 SWOT Analysis

10.8.6 Key Developments

10.9 GSK Plc

10.9.1 Key Facts

10.9.2 Business Description

10.9.3 Products and Services

10.9.4 Financial Overview

10.9.5 SWOT Analysis

10.9.6 Key Developments

11. Appendix

11.1 About The Insight Partners

11.2 Glossary of Terms

List of Tables

Table 1. Asia Pacific Sarcopenia Treatment Market Segmentation

Table 2. Sarcopenia Drug Under Clinical Development

Table 3. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)

Table 4. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type

Table 5. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel

Table 6. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country

Table 7. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 8. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 9. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 10. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 11. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 12. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 13. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 14. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 15. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 16. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 17. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 18. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 19. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market

Table 20. Recent Organic Growth Strategies in the Sarcopenia Treatment Market

Table 21. Glossary of Terms, Sarcopenia Treatment Market

List of Figures

Figure 1. Asia Pacific Sarcopenia Treatment Market Segmentation, By Country

Figure 2. Impact Analysis of Drivers and Restraints

Figure 3. Asia Pacific Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030

Figure 4. Asia Pacific Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030

Figure 5. Vitamin D and Calcium Supplement: Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 6. Protein Supplement : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 7. Vitamin B12 Supplement: Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 8. Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 9. Asia Pacific Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030

Figure 10. Pharmacies : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 11. Retail Channels : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 12. Online Channels : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 13. Others : Asia Pacific Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 14. Asia Pacific Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)

Figure 15. Asia Pacific Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)

Figure 16. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 17. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 18. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 19. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 20. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 21. Rest of Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 22. Growth Strategies in the Sarcopenia Treatment Market

1. Abbott Laboratories 
2. Bayer AG 
3. Metagenics LLC 
4. Nestle Health Science SA 
5. Novartis AG 
6. Pfizer Inc 
7. Sanofi SA 
8. Amway Corp 
9. GSK Plc 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific sarcopenia treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific sarcopenia treatment market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440